CA-1511, In Vitro Radioimmunoassay
by Travenol Laboratories, S.A.
510(k) K841821
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK841821 | Date22 Jun 1984 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JHI
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1155
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 26 Sep 2026
The CA-1511, In Vitro Radioimmunoassay is a diagnostic test system used for the quantitative measurement of human chorionic gonadotropin (hCG) in serum or plasma specimens. It is classified as a Class II medical device under FDA regulation 862.1155 and falls within the Clinical Chemistry specialty.
This device received FDA 510(k) clearance (K841821) on June 22, 1984, and is substantially equivalent to a legally marketed predicate device. It is intended for prescription use and is manufactured by Travenol Laboratories, S.A. The device is supplied as an in vitro assay kit for laboratory use.
Other devices from Travenol Laboratories, S.A.
Questions
AI-generated answers, 26 Sep 2026
What is the CA-1511 In Vitro Radioimmunoassay used for?
The CA-1511 is a diagnostic test system used for the quantitative measurement of human chorionic gonadotropin (hCG) in serum or plasma specimens. It is designed for laboratory use and is intended for prescription purposes.
How is the CA-1511 Radioimmunoassay supplied?
The device is supplied as an in vitro assay kit for laboratory use. It contains all necessary components for performing the quantitative measurement of hCG in serum or plasma specimens according to the manufacturer's instructions.
What is the regulatory status of the CA-1511 Radioimmunoassay?
The CA-1511 received FDA 510(k) clearance (K841821) on June 22, 1984, and is classified as a Class II medical device under FDA regulation 862.1155. It is substantially equivalent to a legally marketed predicate device.
What is the intended use of the CA-1511 test system?
The CA-1511 is intended for the quantitative measurement of human chorionic gonadotropin (hCG) in serum or plasma specimens. This measurement is typically used in clinical settings for various diagnostic purposes related to pregnancy and other conditions.